Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells-Reference-Cited by-同舟云学术

Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells

Published:2016-03 Issue: Volume:5 Page:46-58
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Yin Wenjie,Gorvel Laurent,Zurawski Sandra,Li Dapeng,Ni Ling,Duluc Dorothée,Upchurch Katherine,Kim JongRok,Gu Chao,Ouedraogo Richard,Wang Zhiqing,Xue Yaming,Joo HyeMee,Gorvel Jean-Pierre,Zurawski Gerard,Oh SangKon

Funder

American Cancer Society

National Institutes of Health

Roche

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference61 articles.

1. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation;Belizaire;Proc. Natl. Acad. Sci. U. S. A.,2009

2. Help for cytotoxic-T-cell responses is mediated by CD40 signalling;Bennett;Nature,1998

3. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance;Bonifaz;J. Exp. Med.,2002

4. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination;Bonifaz;J. Exp. Med.,2004

5. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation;Burgdorf;Science,2007

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities;Expert Opinion on Drug Delivery;2024-07-02

2. Next-generation CD40 agonists for cancer immunotherapy;Expert Opinion on Biological Therapy;2024-05-03

3. Engineered Bacteriophage-Based In Situ Vaccine Remodels a Tumor Microenvironment and Elicits Potent Antitumor Immunity;ACS Nano;2024-05-01

4. A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease;Cell Reports Medicine;2024-03

5. XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models;Cancer Immunology, Immunotherapy;2023-10-21